Advertisement · 728 × 90

Posts by Lina Meng, PharmD

Preview
Gut check: antimicrobial stewardship opportunities in intra-abdominal infections | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core Gut check: antimicrobial stewardship opportunities in intra-abdominal infections - Volume 6 Issue 1

Gut check: This review highlights stewardship opportunities in intra-abdominal infections, focusing on SBP prophylaxis, antibiotic management of biliary infections and appendicitis, and optimizing amoxicillin-clavulanate and metronidazole dosing. doi.org/10.1017/ash....

2 months ago 3 3 0 1
Preview
Can implementation of a complex outpatient antimicrobial therapy program reduce readmissions for patients with bone and joint infections? | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core Can implementation of a complex outpatient antimicrobial therapy program reduce readmissions for patients with bone and joint infections? - Volume 6 Issue 1

Creating an advanced practice provider-led Complex Outpatient Antimicrobial Therapy program at our institute improved post-discharge follow-up, strengthened outpatient antimicrobial monitoring and supported timely outpatient interventions for patients with complex infection. doi.org/10.1017/ash....

2 months ago 0 1 0 1
Post image

Feeling the Vibes: An Investigation into Resident Antibiotic Prescribing Practices

✅ Just Accepted
🔗 https://bit.ly/4ablBjg

2 months ago 4 2 1 4
Post image

A warm welcome to our new fellows! We are thrilled to have you on our team, here’s to an exciting journey ahead! Welcome to Stanford ID!

#WelcomeFellows #InfectiousDiseases

4 months ago 7 2 1 0

🩺 Clinically, identifying a lactose fermenting GNR is particularly useful for ruling out Pseudomonas.

⚠️ Many non-lactose fermenters (especially Stenotrophomonas, Burkholderia, and Acinetobacter) can be very challenging to treat. ID consultation should be considered for invasive infections.

5 months ago 4 1 0 0

🌟 ABX Pearl of the Day:

❓ Q: When should I empirically cover for Pseudomonas aeruginosa in diabetic foot infections (DFIs)?

#IDsky #medsky #meded #pharmsky #skyRX #AMSsky

6 months ago 7 3 1 0

🌟 ABX Pearl of the Day:

❓ Q: Candida only grew in 1/4 bottles. Is this a contaminant?

#IDsky #medsky #meded #pharmsky #skyRX #AMSsky

6 months ago 7 3 1 0

Yay! Tara's our awesome ASP track fellow this year - so lucky to get to work with her! @stanfordasp.bsky.social @linameng.bsky.social @dhpharmd.bsky.social @polishmd.bsky.social

6 months ago 2 1 0 0

Risks of ABX overuse greater than benefit? 🤔

7 months ago 0 0 0 0
Advertisement

The same treatment was associated with negative outcomes, including increased hospital readmissions, transfers to the ICU, and longer hospital stays. 🏥

7 months ago 1 0 1 0

The outcome: After adjustment, empiric broad-spectrum antibiotic treatment was not associated with a lower mortality rate. 🚫

7 months ago 1 0 1 0

🔎 The findings: In 2,706 moderately ICH patients with pneumonia, MRSA and resistant GNB were rare, found in just 3.5% of cases. 📉

7 months ago 0 0 1 0

Is empiric MRSA and PsA coverage needed for all moderately ICH with pneumonia? A recent study in CID offers a data-driven look.

So what to do? Check out our ABX pearl on which ICH patients are best candidates for expanded empiric ABX coverage in CAP. ✅

#amssky #Idsky #medsky #pharmsky

7 months ago 4 1 1 0

🌟 ABX Pearl of the Day:

❓ Q: My immunocompromised patient is admitted to the ICU and starting ABX for presumed CAP. Do they need empiric MRSA and Pseudomonas coverage?

#IDsky #medsky #meded #pharmsky #skyRX #AMSsky

7 months ago 11 3 1 1

🌟 ABX Pearl of the Day:

❓ Q: My patient is growing yeast in blood cultures. Is this Candida?

#IDsky #medsky #meded #pharmsky #skyRX #AMSsky

7 months ago 6 5 1 0
2023 AST: CLSI M100 ED33 Updates | News | CLSI Learn about updated aminoglycoside breakpoints in CLSI M100, Edition 33, for key pathogens.

Check this-CLSI eliminated gentamicin as tx option for PsA.

"Review of modern PK/PD) data against members of the Enterobacterales and P. aeruginosa demonstrated:

• No safe aminoglycoside dosing regimen was predicted to achieve bacterial 1- or 2-log killing, regardless of the breakpoint applied."

8 months ago 0 0 1 0
Post image Post image Post image Post image

🔥Finally published🔥
IDSA Guidelines on the Treatment and Management of Complicated Urinary Tract Infections (cUTI)
#idsky
www.idsociety.org/practice-gui...

9 months ago 25 8 2 0

I'm hoping it's because they were super users at baseline 🤓

10 months ago 1 0 0 0
Post image Post image

Implementing microlearning via ABX Pearls emailed to clinicians and trainees weekly at our hospital. 81% reported an impact on their practice, across multiple stewardship domains. 👇🏻

Library here:
med.stanford.edu/bugsanddrugs...

#IDPharmacistsDay #medEd #AMSsky

10 months ago 26 8 3 0
Advertisement

Hi! Lina here from Stanford, CA. I love working with the innovative, bright, open-minded ASP team here @stanfordasp.bsky.social and learning from amazing, dedicated pharmDs/MDs nationally that have propelled ABX stewardship forward tremendously in recent years. #IDpharmacistsday

10 months ago 10 4 0 0
Redirecting

Excited to share our newest paper from my PhD: a post-hoc analysis of the BALANCE trial where we explored heterogeneity of treatment effect (HTE) in duration of antibiotic treatment for patients with bloodstream infection. A thread:

doi.org/10.1016/j.ec...

#IDSky @eclinicalmed.bsky.social

1 year ago 35 15 2 4

🌟 ABX Pearl of the Day: Linezolid drug interactions

❓ Q: I'd like to prescribe linezolid but my patient is on serotonergic agents. What is the incidence of serotonin syndrome with this combination?

#IDsky #medsky #meded #pharmsky #skyRX

1 year ago 16 7 3 1
Post image

We're looking for a new Division Chief in Adult ID at Stanford. We have a great ID/Medicine family here and the division has been growing by leaps and bounds. We also have great Pedi ID, Micro, Immunology and Transplant teams. Please share!

1 year ago 7 5 0 0

Ongoing UCx stewardship efforts at Stanford 🤝 in partnership with infection control, CAUTI taskforce, micro lab, RNs
✔️ 2017: switch to UA with reflex only of wbc>10
✔️2024: a creation of UCx order panel.
🚧 remove UA/UCx orders from surgery pre-op ordersets?
#IDsky #AMSsky

1 year ago 4 1 0 0

#idsky #amssky Anyone using Tamiflu after IV peramivir in ICU patients that gain enteral access? Do people trust IV peramivir efficacy in severe/hospitalized flu?
pubmed.ncbi.nlm.nih.gov/39181595/

1 year ago 3 0 0 0

I learned about this meropenem/VPA drug interaction the hard way as a new practitioner after unsuccessfully dose titrating VPA for days (and wasting 💰). Fortunately VPA indication was for alcohol withdrawal (non benzo ICU protocol at Stanford), not seizures!

See useful tidbits on this interaction👇

1 year ago 2 0 1 0

Yes Epic+beaker. Agh that's tough when you have lab limitations

1 year ago 0 0 0 0

For ceftriaxone-R Enterobacterales from blood, our micro report shows MIC but no interpretation. Instead, displays cautionary comment. Chance for ASP-micro lab collab! 🤝

1 year ago 5 0 2 0

Study shared by esteemed👇 on
pyuria cutoff (in elderly♀️)"At a cutoff of 264 leuk/µL, sensitivity and specificity of microscopy were 88% (positive and negative likelihood ratio: 7.2 and 0.1, respectively). The commonly used cutoff of 10 leuk/µL had a poor specificity (36%) and a sensitivity of 100%."

1 year ago 1 0 1 0
Advertisement

Thrilled to see @conanmacdougall.bsky.social join! 🌟 Your insights are always spot-on. This graph on new ABX approval is spot on. 😂 So true about the emotional rollercoaster—though here, prescribers don't pay attention to drug cost unless formulary restricted. #IDsky #AMSsky #pharmsky #skyrx

1 year ago 13 2 0 0